Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 50.88 USD 0.3% Market Closed
Market Cap: 9.4B USD
Have any thoughts about
Exact Sciences Corp?
Write Note

Exact Sciences Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exact Sciences Corp
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Exact Sciences Corp
NASDAQ:EXAS
Revenue
$2.7B
CAGR 3-Years
15%
CAGR 5-Years
30%
CAGR 10-Years
115%
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%

See Also

What is Exact Sciences Corp's Revenue?
Revenue
2.7B USD

Based on the financial report for Sep 30, 2024, Exact Sciences Corp's Revenue amounts to 2.7B USD.

What is Exact Sciences Corp's Revenue growth rate?
Revenue CAGR 10Y
115%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Exact Sciences Corp have been 15% over the past three years , 30% over the past five years , and 115% over the past ten years .

Back to Top